Product Details
Zithromax
Azithromycin200 mg/5 mL
Oral Liquid
22.5-mL Pack
DIN/PIN/NPN
09857315
Manufacturer
Pfizer Canada Inc.
Formulary Listing Date
2009-03-02
Unit Price
NA
Amount MOH Pays
NA
Coverage Status
Not a Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Antibiotics, Erythromycins (08:12:12):
Erythromycin alone is not adequate for the treatment of H. influenzae infections. It lacks consistently reliable activity against this organism. Erythromycin is a potent inhibitor of hepatic oxidation of some drugs and may cause significant elevation of blood levels of astemizole, carbamazepine, cyclosporine, digoxin, dihydropyridines, terfenadine, theophylline and warfarin. Potentially fatal arrhythmias (torsade de pointes) can occur with the combination of erythromycin and astemizole or terfenadine.
ATC Code
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 09857315 | Zithromax | NA | NA |
| 09857351 | Sandoz Azithromycin | 18.7425 | 18.7425 |
| 09857636 | Auro-Azithromycin | 18.7425 | 18.7425 |
LU Clinical Criteria
NORequirements